JP2002515439A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002515439A5 JP2002515439A5 JP2000549264A JP2000549264A JP2002515439A5 JP 2002515439 A5 JP2002515439 A5 JP 2002515439A5 JP 2000549264 A JP2000549264 A JP 2000549264A JP 2000549264 A JP2000549264 A JP 2000549264A JP 2002515439 A5 JP2002515439 A5 JP 2002515439A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- method described
- liquid carrier
- carrier
- phosphocholine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004480 active ingredient Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 3
- MHFRGQHAERHWKZ-HHHXNRCGSA-N (R)-edelfosine Chemical compound CCCCCCCCCCCCCCCCCCOC[C@@H](OC)COP([O-])(=O)OCC[N+](C)(C)C MHFRGQHAERHWKZ-HHHXNRCGSA-N 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19822509A DE19822509A1 (de) | 1998-05-19 | 1998-05-19 | Edelfosin zur Behandlung von Hirntumoren |
| DE19822509.1 | 1998-05-19 | ||
| PCT/EP1999/003241 WO1999059599A1 (de) | 1998-05-19 | 1999-05-11 | Edelfosin zur behandlung von hirntumoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002515439A JP2002515439A (ja) | 2002-05-28 |
| JP2002515439A5 true JP2002515439A5 (enExample) | 2006-07-13 |
Family
ID=7868323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000549264A Pending JP2002515439A (ja) | 1998-05-19 | 1999-05-11 | 脳腫瘍の治療のためのエーデルホシン |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6514519B1 (enExample) |
| EP (1) | EP1079838B1 (enExample) |
| JP (1) | JP2002515439A (enExample) |
| AT (1) | ATE223721T1 (enExample) |
| DE (2) | DE19822509A1 (enExample) |
| WO (1) | WO1999059599A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002531534A (ja) * | 1998-12-04 | 2002-09-24 | マックス−デルブルック−セントラム フュール モレクラーレ メディツィン | タモキシフェン含有リポソーム系腫瘍治療剤 |
| US7041302B2 (en) | 2001-01-09 | 2006-05-09 | Biother Corporation | Therapeutic modulation of the tumor inflammatory response |
| EP1876900A4 (en) * | 2005-05-02 | 2009-06-24 | Univ Columbia | PHOSPHOINOSITIDE MODULATION FOR THE TREATMENT OF ALZHEIMER DISEASE |
| DE102006019907A1 (de) * | 2006-04-28 | 2007-10-31 | Müller-Enoch, Dieter, Prof. Dr. | Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung |
| DK2091520T3 (da) * | 2006-11-10 | 2012-06-18 | Alphaptose Gmbh | Oral doseringsform omfattende trisubstituerede glycerol-forbindelser |
| WO2008055997A1 (en) * | 2006-11-10 | 2008-05-15 | Alphaptose Gmbh | Use of tri-substituted glycerol compounds for the treatment of radiation injuries |
| JP5773569B2 (ja) * | 2006-11-10 | 2015-09-02 | アルファプトーゼ ゲーエムベーハーＡｌｐｈａｐｔｏｓｅ Ｇｎｂｈ | 受容体リガンド模倣体を検出する方法 |
| EP2117555B1 (en) | 2006-12-20 | 2012-10-17 | Universitätsklinikum Hamburg-Eppendorf | Use of tri-substituted glycerol compounds for the treatment of hematological malignancies |
| EP2120873B1 (en) * | 2006-12-20 | 2012-06-27 | Alphaptose Gmbh | Topical dosage form comprising tri-substituted glycerol compounds |
| CA2687330A1 (en) | 2007-05-18 | 2008-11-27 | The Johns Hopkins University | A treatment simulator for brain diseases and method of use thereof |
| RU2382765C1 (ru) * | 2008-10-24 | 2010-02-27 | Государственное образовательное учреждение высшего профессионального образования "Московская государственная академия тонкой химической технологии имени М.В. Ломоносова" | Rac-N,N-ДИМЕТИЛ-N-[2-(5-N',N'- ДИМЕТИЛАМИНОНАФТАЛЕН-1-СУЛЬФОНИЛОКСИ)ЭТИЛ]-N- {4-[(2-МЕТОКСИ-3-ОКТАДЕЦИЛОКСИ)ПРОП-1-ИЛОКСИКАРБОНИЛ]БУТИЛ} АММОНИЙИОДИД |
| WO2013156630A1 (en) | 2012-04-20 | 2013-10-24 | Alphaptose Gmbh | S-enantiomer of a tri-substituted glycerol compound |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3941009A1 (de) * | 1989-12-12 | 1991-06-13 | Medmark Pharma Gmbh | Eliminierung von aktivierten lymphozyten |
| DE4000084A1 (de) * | 1990-01-03 | 1991-07-04 | Medmark Pharma Gmbh | Intravenoes applizierbare pharmazeutische zubereitung von et18-och(pfeil abwaerts)3(pfeil abwaerts) |
| US5925669A (en) * | 1994-03-22 | 1999-07-20 | Molecular/Structural Bio Technologies, Inc. | Carrier compositions for anti-neoplastic drugs |
| AU2545697A (en) * | 1996-03-27 | 1997-10-17 | Uab Research Foundation | Novel uses of phospholipase c inhibitors |
-
1998
- 1998-05-19 DE DE19822509A patent/DE19822509A1/de not_active Withdrawn
-
1999
- 1999-05-11 DE DE59902666T patent/DE59902666D1/de not_active Expired - Lifetime
- 1999-05-11 AT AT99952070T patent/ATE223721T1/de not_active IP Right Cessation
- 1999-05-11 US US09/700,903 patent/US6514519B1/en not_active Expired - Fee Related
- 1999-05-11 EP EP99952070A patent/EP1079838B1/de not_active Expired - Lifetime
- 1999-05-11 WO PCT/EP1999/003241 patent/WO1999059599A1/de not_active Ceased
- 1999-05-11 JP JP2000549264A patent/JP2002515439A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL113651A0 (en) | Pharmaceutical compositions containing alendronate and their use | |
| JP2003504333A (ja) | 必須脂肪酸およびホモシステイン低下剤を含有する製剤および栄養組成物 | |
| GEP20063895B (en) | Platinum derivative pharmaceutical formulations | |
| WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
| CA2366841A1 (en) | Tolperisone-containing pharmaceutical preparation for oral administration | |
| JP2002524415A5 (enExample) | ||
| US4590213A (en) | Anti-anxiety method | |
| WO2000041504A3 (en) | Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides | |
| US4438138A (en) | Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone | |
| US5753712A (en) | Treatment of migraine headaches and formulations | |
| RU2004131214A (ru) | Способы лечения когнитивных расстройств | |
| TW200534852A (en) | 4-methylpyrazole formulations for inhibiting ethanol intolerance | |
| CA2474430A1 (en) | A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction | |
| IT1314199B1 (it) | Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita' | |
| WO2005013935A3 (en) | Composition for releasing a weak base for an extended period of time | |
| WO2000026185A3 (en) | Omeprazole solution and method of using same | |
| JP2003002827A5 (enExample) | ||
| JP2001316293A5 (enExample) | ||
| RU99112967A (ru) | Способ лечения и профилактики дизентерии свиней | |
| JPH0680564A (ja) | 抗色素沈着治療薬 | |
| RU2003106417A (ru) | Применение комбинации витаминов для лечения первичных головных болей | |
| WO2004050019A3 (en) | Method and compositions for treating anxiety | |
| KR920703593A (ko) | 이미다조퀴녹살린 화합물, 이의 제조방법 및 용도 | |
| RU93014953A (ru) | Препарат для лечения эндометрита у коров |